BPC-157 Complete Guide: Body Protection Compound for Gut Healing & Tendon Repair

BPC-157 is one of the most researched and widely discussed peptides in the performance and recovery space. Short for Body Protection Compound-157, this synthetic peptide is derived from a naturally occurring protein found in human gastric juice. Over the past two decades, animal research has revealed a remarkable range of healing properties — from repairing the gut lining to accelerating tendon recovery — making BPC-157 a staple topic among biohackers, athletes, and clinicians exploring peptide therapy.

This guide covers everything you need to know: what BPC-157 is, how it works, how to dose it, and what the evidence actually says.

What Is BPC-157?

BPC-157 is a pentadecapeptide — a chain of 15 amino acids — first isolated from human gastric juice. The full sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It does not occur naturally on its own but is a fragment of the larger body protection compound found in gastric secretions, where it likely plays a role in mucosal protection.

In its research form, BPC-157 is a stable synthetic analog that resists enzymatic degradation, which is what makes it so effective when administered orally or via injection.

Mechanism of Action

BPC-157 exerts its effects through several complementary pathways:

Nitric Oxide Modulation

BPC-157 upregulates nitric oxide synthase (NOS), increasing local nitric oxide production. Nitric oxide is critical for vasodilation, angiogenesis (formation of new blood vessels), and tissue perfusion. This mechanism explains much of its healing effect in tendons, ligaments, and the gut.

Growth Factor Upregulation

Research shows BPC-157 increases expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF), both of which are essential for tissue repair and the formation of new connective tissue.

Tendon Fibroblast Stimulation

BPC-157 directly stimulates tendon fibroblasts — the cells responsible for producing collagen — accelerating the rate of tendon repair. Animal models of Achilles tendon transection show significantly faster healing with BPC-157 compared to controls.

Gut Mucosal Protection

In the gut, BPC-157 protects the mucosal lining from NSAID-induced damage, promotes healing of inflammatory bowel conditions, and appears to modulate the enteric nervous system. It also counteracts the negative effects of alcohol and other toxins on GI tissue.

Dopamine and Serotonin Interactions

BPC-157 has been shown to interact with dopaminergic and serotonergic systems in the central nervous system, which may explain reported improvements in mood and stress tolerance in animal studies.

Oral vs. Injectable: Which Is Better?

This is one of the most common questions about BPC-157, and the honest answer is: it depends on your goal.

Injectable BPC-157

Subcutaneous or intramuscular injection delivers BPC-157 directly into systemic circulation with high bioavailability. Injecting near an injury site (e.g., subcutaneously near a damaged tendon) appears to concentrate its effects locally. Injectable BPC-157 is generally preferred for systemic or musculoskeletal applications.

Oral BPC-157

Because BPC-157 is remarkably stable in gastric acid — unlike most peptides — oral administration is effective for gut-related conditions. Studies in rodents show oral BPC-157 heals intestinal anastomoses, reduces intestinal fistulas, and improves inflammatory bowel conditions. For gut healing specifically, oral may actually be the superior route.

Capsule vs. Liquid

Some users take BPC-157 in capsule form or dissolved in a bacteriostatic water solution taken orally. Both routes appear to work for GI applications. For systemic healing, injection remains the more reliable option.

Dosing Protocols

Typical research-based dosing ranges:

• Standard dose: 250–500 mcg per injection, 1–2 times daily
• Oral dose (gut healing): 250–500 mcg, 1–2 times daily, taken on an empty stomach
• Cycle length: 4–8 weeks, followed by a break of 4 weeks
• Injection site: Subcutaneous injection near the injury site or in abdominal fat

Most users report noticeable effects within 1–2 weeks of consistent use, with significant improvements in soft tissue pain and GI symptoms often noted by weeks 3–4.

What BPC-157 Is Used For

Gut Healing and IBD

BPC-157 may be the most promising peptide for gastrointestinal conditions. Animal studies show efficacy in healing intestinal fistulas, protecting against NSAID-induced ulcers, reducing inflammatory bowel disease markers, and accelerating recovery from intestinal surgery.

Tendon and Ligament Repair

One of the most well-documented uses in animal research is accelerated tendon healing. BPC-157 has shown efficacy in Achilles tendon rupture models, rotator cuff injuries, patellar tendon damage, and MCL tears.

Muscle Healing

Beyond tendons, BPC-157 promotes muscle fiber regeneration and reduces delayed onset muscle soreness (DOMS) in research models.

Bone Healing

Some research suggests BPC-157 accelerates bone fracture healing through its angiogenic and growth factor-stimulating effects.

Neuroprotection

Animal studies have shown BPC-157 to be neuroprotective following traumatic brain injury and to improve outcomes in models of Parkinson's disease, potentially through its dopamine-modulating effects.

Side Effects and Safety

BPC-157 has an excellent safety profile in animal studies. No LD50 (lethal dose) has been established in rodents, even at very high doses. Reported side effects in humans (anecdotal) are generally mild:

• Nausea (more common with oral dosing)
• Dizziness or lightheadedness (rare)
• Injection site irritation (mild, transient)
• Vivid dreams or changes in sleep (occasional reports)

Because BPC-157 promotes angiogenesis and growth factor upregulation, there is a theoretical concern about its use in individuals with active cancer or pre-cancerous conditions. This has not been studied in humans, but represents a logical precaution.

Legal and Regulatory Status

BPC-157 is not FDA-approved for any indication in humans. It is classified as a research chemical and is legal to purchase for laboratory research purposes in the United States. It has not completed Phase 2 or Phase 3 clinical trials in humans, so its clinical use remains off-label.

In 2022, the FDA issued guidance restricting the compounding of BPC-157 by licensed compounding pharmacies, citing concerns about its novel drug status. This has limited access through some clinical channels in the US.

Stacking BPC-157

BPC-157 is commonly paired with:

• TB-500/Thymosin Beta-4 — for synergistic tissue repair
• Sermorelin or GHRP-6 — for enhanced recovery and body composition
• Thymosin Alpha-1 — for immune modulation alongside healing

Frequently Asked Questions

Q: Can BPC-157 be taken orally for gut healing? Yes. BPC-157 is unusually stable in gastric acid, making oral administration effective for gastrointestinal conditions like IBD, leaky gut, and ulcers. Most other peptides are degraded by stomach acid and require injection.

Q: How long does BPC-157 take to work? Most users report initial improvements within 1–2 weeks. For tendon injuries, meaningful structural repair typically requires 4–6 weeks of consistent use. Gut healing improvements are often noticed more quickly, sometimes within days.

Q: Is BPC-157 safe for long-term use? No long-term human safety data exists. Animal studies suggest a very high safety margin. Most practitioners recommend cycling (e.g., 8 weeks on, 4 weeks off) out of caution rather than evidence of harm.

Q: Does BPC-157 require refrigeration? Lyophilized (powder) BPC-157 is stable at room temperature for short periods but should be stored in a freezer for long-term storage. Once reconstituted in bacteriostatic water, it should be refrigerated and used within 4–6 weeks.

Q: Can BPC-157 cause cancer? No human or animal data establishes BPC-157 as carcinogenic. However, because it promotes angiogenesis and growth factors, its use in individuals with active cancer is not recommended until more data is available.

Q: What is the best injection site for BPC-157? For localized injury repair, injecting subcutaneously near the injury site (within a few centimeters) appears to concentrate the healing effect. For systemic effects, subcutaneous injection in abdominal fat is the most common and convenient approach.